Latest news

Thumbnail image for COPD survey reveals gaps in care

COPD survey reveals gaps in care

A survey of 500 people across Britain diagnosed with chronic obstructive pulmonary disease (COPD) has revealed that almost a third (31 percent) feel their treatment is not adequately controlling their condition.

17th November 2017

Thumbnail image for Roche bags new approvals for Hemlibra, Gazyva

Roche bags new approvals for Hemlibra, Gazyva

US regulators have issued a green light for Roche’s haemophilia A therapy Hemlibra and also expanded the scope of Gazyva to include untreated advanced follicular lymphoma.

17th November 2017

Thumbnail image for Fill out the MCQ today

Fill out the MCQ today

PharmaTimes Clinical Researcher of the Year - The Americas is now open for entry.

17th November 2017

Thumbnail image for EU advisors back expanding use of Adcetris

EU advisors back expanding use of Adcetris

Takeda’s Adcetris could soon be on the market in Europe as a second-line treatment for adults with CD30-positive cutaneous T-cell lymphoma (CTCL) after regulatory advisors backed expanding the drug’s scope.

16th November 2017

Thumbnail image for Green light for minimum alcohol pricing in Scotland

Green light for minimum alcohol pricing in Scotland

Health officials have welcomed a decision by the Supreme Court that allows the introduction of minimum unit pricing in Scotland, which sets a minimum unit price of 50 pence per unit for alcohol.

16th November 2017

Thumbnail image for GSK, Innoviva’s Trelegy Ellipta cleared for COPD

GSK, Innoviva’s Trelegy Ellipta cleared for COPD

GlaxoSmithKline and Innoviva have won European approval for the novel triple therapy inhaler Trelegy Ellipta, offering a new treatment option for patients with Chronic Obstructive Pulmonary Disorder (COPD).

16th November 2017

Thumbnail image for NICE waves through breast cancer drugs following price deals

NICE waves through breast cancer drugs following price deals

The National Institute for Health and Care Excellence is backing routine NHS funding for Pfizer's Ibrance and Novartis' Kisqali to treat certain forms of breast cancer, after the firms agreed to provide them at a reduced price under the new process for appraising medicines.

16th November 2017

Thumbnail image for Bayer, Loxo link in $1.55bn cancer drugs deal

Bayer, Loxo link in $1.55bn cancer drugs deal

Bayer and Loxo Oncology have agreed to work together on the development and commercialisation of two novel cancer therapies, in a deal potentially worth more than $1.5 billion to the latter firm.

15th November 2017

Thumbnail image for EU approves subcutaneous form of GSK’s Benlysta

EU approves subcutaneous form of GSK’s Benlysta

A new subcutaneous formulation of GlaxoSmithKline’s Benlysta has been approved as an add-on therapy for certain in adults with the autoimmune disease systemic lupus erythematosus (SLE).

15th November 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download